In vitro characterization of the human biotransformation pathways of aplidine, a novel marine anti-cancer drug

E.F.A. Brandon; R.W. Sparidans; R.D. van Ooijen; I. Meijerman; L.L. Lazaro; I. Manzanares; J.H. Beijnen; J.H.M. Schellens

In vitro characterization of the human biotransformation pathways of aplidine, a novel marine anti-cancer drug

E.F.A. Brandon
, R.W. Sparidans
, R.D. van Ooijen
, I. Meijerman
, L.L. Lazaro
, I. Manzanares
, J.H. Beijnen
, J.H.M. Schellens

Dept of Pharmaceutical Sciences

extern

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	9-19
Number of pages	11
Journal	Investigational New Drugs
Volume	25
Publication status	Published - 2007

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Farmacie/Biofarmaceutische wetenschappen (FARM)
Farmacie(FARM)

Cite this

@article{f2a3cb98f7584c179aeeeb3ab1ae4508,

title = "In vitro characterization of the human biotransformation pathways of aplidine, a novel marine anti-cancer drug",

keywords = "Farmacie/Biofarmaceutische wetenschappen (FARM), Farmacie(FARM)",

author = "E.F.A. Brandon and R.W. Sparidans and \{van Ooijen\}, R.D. and I. Meijerman and L.L. Lazaro and I. Manzanares and J.H. Beijnen and J.H.M. Schellens",

year = "2007",

language = "Undefined/Unknown",

volume = "25",

pages = "9--19",

journal = "Investigational New Drugs",

issn = "0167-6997",

publisher = "Springer",

}

TY - JOUR

T1 - In vitro characterization of the human biotransformation pathways of aplidine, a novel marine anti-cancer drug

AU - Brandon, E.F.A.

AU - Sparidans, R.W.

AU - van Ooijen, R.D.

AU - Meijerman, I.

AU - Lazaro, L.L.

AU - Manzanares, I.

AU - Beijnen, J.H.

AU - Schellens, J.H.M.

PY - 2007

Y1 - 2007

KW - Farmacie/Biofarmaceutische wetenschappen (FARM)

KW - Farmacie(FARM)

M3 - Article

SN - 0167-6997

VL - 25

SP - 9

EP - 19

JO - Investigational New Drugs

JF - Investigational New Drugs

ER -